Go Deep
Wave Life Sciences, Inc.
Wave Life Sciences, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,118 | -2.9 | 1.36 | 0.10 | 299.03 |
| Oct 2026 | 23,140 | -2.9 | 1.34 | 0.10 | 293.39 |
| Oct 2026 | 23,095 | -3.0 | 1.39 | 0.10 | 302.93 |
| Oct 2026 | 23,124 | -2.9 | 1.36 | 0.10 | 296.46 |
| Oct 2026 | 23,106 | -2.9 | 1.38 | 0.10 | 300.57 |
| Oct 2026 | 22,994 | -3.2 | 1.49 | 0.10 | 324.27 |
| Oct 2026 | 23,016 | -3.1 | 1.46 | 0.10 | 318.74 |
| Oct 2026 | 23,025 | -3.1 | 1.46 | 0.10 | 316.21 |
Wave Life Sciences, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 2,272,000.0 | 38,246,000.0 | 17,245,000.0 | 7,608,000.0 |
| Net Profit | -69,355,000.0 | -26,087,000.0 | -53,179,000.0 | -53,852,000.0 |
| EPS | -0.3 | -0.1 | -0.3 | -0.3 |
Wave Life Sciences, Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 42,727,000.0 | 108,302,000.0 | 113,305,000.0 | 3,649,000.0 |
| Net Profit | -204,378,000.0 | -97,008,000.0 | -57,513,000.0 | -161,823,000.0 |
| EPS | -1.2 | -0.7 | -0.5 | -2.0 |
Wave Life Sciences, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Total Assets | 638,499,000.0 | 352,207,000.0 | 274,949,000.0 | 146,386,000.0 |
| Total Liabilities | 120,142,000.0 | 142,692,000.0 | 235,319,000.0 | 191,477,000.0 |
| Total Equity | 518,357,000.0 | 209,515,000.0 | 39,630,000.0 | -45,091,000.0 |
Owes vs Owns
Wave Life Sciences, Inc. owed $0.19 for every $1 it owned in Jun 2026, down from $1.31 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.19× | 0.19× | 0.41× | 0.86× | 1.31× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Wave Life Sciences, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 94.3%Fixed assets (tangible) 3.1%Other assets 2.4%
How it's funded — Dec 2025
Short-term debt 1.3%Long-term debt 1.5%Payables 2.5%Other liabilities 13.6%Shareholders' equity 81.2%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 602.1 | 302.1 | 200.4 | 88.5 |
| Receivables | 1.3 | 1.4 | 21.1 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 19.9 | 28.0 | 35.7 | 44.1 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 15.3 | 20.7 | 17.8 | 13.8 |
| Liabilities & equity | ||||
| Short-term debt | 8.4 | 7.6 | 6.7 | 5.5 |
| Long-term debt | 9.4 | 17.8 | 25.4 | 32.1 |
| Payables | 15.7 | 16.3 | 12.8 | 16.9 |
| Other liabilities | 86.7 | 101.0 | 190.4 | 136.9 |
| Shareholders' equity | 518.4 | 209.5 | 39.6 | -45.1 |
| Net tangible assets | 518.4 | 209.5 | 39.6 | -45.1 |
Wave Life Sciences, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -187,493,000.0 | -151,026,000.0 | -19,431,000.0 | -127,781,000.0 | — |
| Investing Activities | -718,000.0 | -938,000.0 | -1,115,000.0 | -1,255,000.0 | — |
| Financing Activities | 488,235,000.0 | 253,890,000.0 | 132,534,000.0 | 67,188,000.0 | — |